We were talking about disclosure wordsmith. I.e duty y to keep the market accurately informed about timeframes and updating the market on any issues causing the timeframes to blow out.
My point is, if the telephone conversation note (Virtuosa / PN) is accurate, then:
1- when did they realise that there was issue with the CRP and pivot to one trial at a time?
2- why didn't they update the market accordingly.
If the CRO mistake happened before the AGM then "final throes" line is doubtful, but even if the cro mistake / issue happened after the AGM, it's hard to see how the results were in final throes. Again in 14 December 2023, "look forward... releasing 3 clinical trials in coming weeks".
All a bit of a mess. Be interesting to see if they can the results out this quarter as promised. T-14
$10 Billion Deal, page-13023
-
- There are more pages in this discussion • 245 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
